Biopolitical News of the Year 2013
By Pete Shanks,
Biopolitical Times
| 12. 19. 2013
For better and worse, 2013 has been a year in which several related issues familiar to those who follow human biotechnology moved into the wider sphere of public discussion. Many involve genetic testing – at every stage of life – and some explicitly raise issues of inheritable genetic modification. The legacy of eugenics past, the horror of sterilization abuse in the present, and the advocacy of genetic selection for intelligence and other traits in the near future all hit the headlines.
The U.S. Supreme Court issued a series of important and yet strangely incomplete rulings whose implications are still being unraveled. The commercialization of synthetic biology and other newly developed technologies proceeded apace, with well-financed businesses, partly crowd-sourced ventures and a number of outright scams. The assisted reproduction industry continued its global spread, and there were encouraging signs of academic interest in analyzing its processes.
Here are our picks for the top biopolitical news stories of 2013:
- Testing, Testing …
- “Three-Parent” Babies and Inheritable Genetic Modification
- Eugenics: Past and Present as Prologue
- IQ and Genetics and Education and Immigration
- A...
Related Articles
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...
Faster, Higher, Stronger was the Olympic motto from 1874 until 2001, when “ – Together” was added, to stress the “moral and educational perspective” of the Games. The folks who paid for or participated in the Enhanced Games – the name itself a nod to the Olympics – held in Las Vegas on Sunday, May 24, apparently use a different edit:
Faster, Higher, Stronger with Chemistry
High-level sport draws huge crowds. Coming very soon, the soccer World Cup, featuring...
By Gina Kolata, The New York Times | 05.25.2026
In a small, preliminary study, an experimental gene-editing treatment dramatically lowered cholesterol levels, perhaps permanently, after just one infusion, scientists reported on Monday.
If confirmed in larger studies, researchers hope the findings may lead to a one-and-done way to prevent...
By Ryan Cross, Endpoint News | 05.20.2026
BOSTON — Over the past year, I’ve begun hearing rumblings from scientists who secretly think it’s time to stop being stodgy about editing the genes of human embryos.
For the most part, they are still too timid to speak up...
